Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received May 2, 2013
- Revision received May 24, 2013
- Accepted May 28, 2013
- Published online July 29, 2013.
Copyright & Usage
Copyright© 2013 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
Author Information
- FABLE ZUSTOVICH1⇑,
- LORENZA LANDI2,
- GIUSEPPE LOMBARDI2,
- CAMILLO PORTA3,
- LUCA GALLI4,
- ANDREA FONTANA4,
- DOMENICO AMOROSO5,
- COSTANZA GALLI6,
- MICHELE ANDREUCCETTI7,
- ALFREDO FALCONE4 and
- VITTORINA ZAGONEL1
- 1Istituto Oncologico Veneto–IRCCS, Medical Oncology 1, Padova, Italy
- 2Oncologia Medica, Azienda USL 6, Istituto Toscano Tumori, Livorno, Italy
- 3Oncologia Medica–IRCCS Policlinico S. Matteo, Pavia, Italy
- 4U.O. Oncologia Universitaria, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy
- 5Oncologia Medica, Ospedale Versilia, Viareggio, Italy
- 6Unità Funzionale Cure Palliative, Azienda USL 6, Livorno, Italy
- 7IRCCS–Istituto Toscano Tumori, Firenze, Italy
- Correspondence to: F. Zustovich, Istituto Oncologico Veneto–IRCCS, Medical Oncology 1 - Via Gattamelata, 64, 35128 Padova, Italy. E-mail: fable.zustovich{at}ioveneto.it
Cited By...
In this issue
Sorafenib plus Daily Low-dose Temozolomide for Relapsed Glioblastoma: A Phase II Study
Jump to section
Related Articles
Cited By...
- No citing articles found.